Confidential Data Room

Investor & partner data room

Email-verified access to confidential preclinical, regulatory, and intellectual-property documentation for Xycota’s XYCO-02 (mild PTSD) and XYCO-01 (FTD) programs. All programs are preclinical and investigational.

01 · Eligibility

Who qualifies, and who this is not for

Eligible parties: Institutional life-science investors, pharmaceutical and biotechnology licensing executives, and clinical or academic research institutions evaluating partnering or diligence under NDA.

Who this is not for: Xycota is not conducting a public offering. No offering document exists, and nothing in this data room constitutes, contains, or precedes one.

Access is not available to individual or retail investors, or to shareholders or prospective shareholders of any company. Requests from those parties will not be processed.

02 · Data Room Index

What approved applicants can access

Preclinical pharmacology & study reports: Full data tables and behavioral/biochemical protocols from the 2026 Neuropsychopharmacology rat study and ongoing translational planning.
Regulatory & clinical documentation: XYCO-02 Health Canada CTA preparation materials with CRO partner KGK Science, and XYCO-01 FDA Orphan Drug Designation (ODD) filing documentation.
Intellectual property & corporate docket: Provisional patent schedules, claims scope for XYCO-02 and XYCO-01, and corporate governance documents.

03 · Request Action

Verify eligibility & request access

Access is email-verified. Confirm the institutional eligibility and confidentiality attestations below to proceed to the secure data room portal.

Request Institutional Access →

Opens Xycota's secure data room in a new tab, where you will verify your institutional email address before documents load. Questions or direct introductions: brad@xycota.com.